Altria Group's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Altria Group (MO)

Q1 2012 Earnings Call

April 26, 2012 9:00 am ET

Executives

Brendan McCormick - Vice President of Communications

Michael E. Szymanczyk - Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Philip Morris USA Inc

Howard A. Willard - Chief Financial Officer and Executive Vice President

Analysts

Nik Modi - UBS Investment Bank, Research Division

Vivien Azer - Citigroup Inc, Research Division

Christopher Ferrara - BofA Merrill Lynch, Research Division

Judy E. Hong - Goldman Sachs Group Inc., Research Division

Christina McGlone - Deutsche Bank AG, Research Division

David J. Adelman - Morgan Stanley, Research Division

Thilo Wrede - Jefferies & Company, Inc., Research Division

Michael Lavery - CLSA Asia-Pacific Markets, Research Division

Christopher Growe - Stifel, Nicolaus & Co., Inc., Research Division

Ann H. Gurkin - Davenport & Company, LLC, Research Division

Presentation

Operator

Good day, and welcome to the Altria Group 2012 First Quarter Earnings Conference Call. Today's call is scheduled to last about 1 hour, including remarks by Altria's management and a question-and-answer session. [Operator Instructions] I would now like to turn the call over to Mr. Brendan McCormick, Vice President, Investor Relations for Altria Client Services. Please go ahead, sir.

Brendan McCormick

Good morning. Thank you for joining our call. I'm joined this morning by Mike Szymanczyk, Altria's Chairman and CEO; and Howard Willard, Altria's Chief Financial Officer. This morning, we will only be discussing Altria's 2012 business results for the first quarter, and we'll not be discussing the status of tobacco litigation.

Our remarks contain forward-looking and cautionary statements and projections of future results, and I direct your attention to the forward-looking and cautionary statement section at the end of our earnings release for the review of the various factors that could cause actual results to differ materially from projections. For a detailed review of Altria's business results, please review the earnings release that is available on our website, altria.com.

If you liked this article you might like

STMicroelectronics, Intercept Pharmaceuticals: 'Mad Money' Lightning Round

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

These Stocks Pay You to Own Them

From the Marlboro Man to Vaping, Here Are the Events that Shaped Big Tobacco

Tobacco Stocks Mixed as FDA Launches Campaign to Keep Kids Away From E-Cigarettes